The FDA on Tuesday approves Ozempic, the weight loss drug made by Novo Nordisk, for the treatment of chronic kidney disease in patients who also have type 2 diabetes.
Ozempic Receives FDA Approval To Treat Kidney Disease
Where Today's News Shapes Tomorrow
